ArticleMolecular and clinical oncology2025

Prolonged exposure to axitinib alters the molecular profile of Caki-2 renal cell carcinoma cells.

Yuko Nakayama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.